Cerebellar-cortical function and connectivity during sensorimotor behavior in aging FMR1 gene premutation carriers.

Cerebellar Crus I Extrastriate cortex FMR1 premutation Fragile X-associated tremor/ataxia syndrome (FXTAS) Functional connectivity Sensorimotor

Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 12 05 2020
revised: 23 06 2020
accepted: 24 06 2020
pubmed: 28 7 2020
medline: 29 6 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

Premutation carriers of the FMR1 gene are at risk of developing fragile X-associated tremor/ataxia syndrome (FXTAS), a neurodegenerative disease characterized by motor, cognitive, and psychiatric decline as well as cerebellar and cerebral white matter pathology. Several studies have documented preclinical sensorimotor issues in aging premutation carriers, but the extent to which sensorimotor brain systems are affected and may represent early indicators of atypical neurodegeneration has not been determined. Eighteen healthy controls and 16 FMR1 premutation carriers (including five with possible, probable, or definite FXTAS) group-matched on age, sex, and handedness completed a visually guided precision gripping task with their right hand during fMRI. During the test, they used a modified pinch grip to press at 60% of their maximum force against a custom fiber-optic transducer. Participants viewed a horizontal white force bar that moved upward with increased force and downward with decreased force and a static target bar that was red during rest and turned green to cue the participant to begin pressing at the beginning of each trial. Participants were instructed to press so that the white force bar stayed as steady as possible at the level of the green target bar. Trials were 2-sec in duration and alternated with 2-sec rest periods. Five 24-sec blocks consisting of six trials were presented. Participants' reaction time, the accuracy of their force relative to the target force, and the variability of their force accuracy across trials were examined. BOLD signal change and task-based functional connectivity (FC) were examined during force vs. rest. Relative to healthy controls, premutation carriers showed increased trial-to-trial variability of force output, though this was specific to younger premutation carriers in our sample. Relative to healthy controls, premutation carriers also showed reduced extrastriate activation during force relative to rest. FC between ipsilateral cerebellar Crus I and extrastriate cortex was reduced in premutation carriers compared to controls. Reduced Crus I-extrastriate FC was related to increased force accuracy variability in premutation carriers. Increased reaction time was associated with more severe clinically rated neurological abnormalities. Findings of reduced activation in extrastriate cortex and reduced Crus I-extrastriate FC implicate deficient visual feedback processing and reduced cerebellar modulation of corrective motor commands. Our results are consistent with documented cerebellar pathology and visual-spatial processing in FXTAS and pre-symptomatic premutation carriers, and suggest FC alterations of cerebellar-cortical networks during sensorimotor behavior may represent a "prodromal" feature associated with FXTAS degeneration.

Identifiants

pubmed: 32711390
pii: S2213-1582(20)30169-8
doi: 10.1016/j.nicl.2020.102332
pmc: PMC7381687
pii:
doi:

Substances chimiques

FMR1 protein, human 0
Fragile X Mental Retardation Protein 139135-51-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102332

Subventions

Organisme : NICHD NIH HHS
ID : U54 HD090216
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Trends Cogn Sci. 1998 Sep 1;2(9):338-47
pubmed: 21227230
Arch Neurol. 2012 Apr;69(4):482-9
pubmed: 22491193
Nature. 1986 Sep 18-24;323(6085):217-21
pubmed: 3762673
Neuroimage. 2010 Sep;52(3):1015-26
pubmed: 20056151
Neuroreport. 2004 Jun 7;15(8):1315-9
pubmed: 15167557
Hum Brain Mapp. 2013 Mar;34(3):698-712
pubmed: 22109998
J Neuroeng Rehabil. 2019 Jul 12;16(1):87
pubmed: 31299981
Neuroscience. 2012 Mar 29;206:183-9
pubmed: 22266345
J Int Neuropsychol Soc. 2011 Jul;17(4):746-50
pubmed: 21554789
J Appl Physiol (1985). 2003 Mar;94(3):903-12
pubmed: 12571125
Ann Neurol. 2003 May;53(5):616-23
pubmed: 12730995
Neurology. 2007 Aug 28;69(9):851-9
pubmed: 17724287
Parkinsonism Relat Disord. 2014 Apr;20(4):456-9
pubmed: 24491663
Cerebellum. 2015 Dec;14(6):650-62
pubmed: 25763861
Neurobiol Aging. 2014 Sep;35(9):2179.e7-13
pubmed: 24814676
Neuron. 2002 May 16;34(4):647-58
pubmed: 12062047
Arch Neurol. 2008 Apr;65(4):495-8
pubmed: 18413472
Front Neurosci. 2018 Jun 25;12:379
pubmed: 29988561
Hum Brain Mapp. 2015 Apr;36(4):1554-66
pubmed: 25598397
AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1715-21
pubmed: 15569736
Vis Neurosci. 2015 Jan;32:E014
pubmed: 26241035
J Psychiatr Res. 2011 Jan;45(1):36-43
pubmed: 20537351
Clin Genet. 2015 Feb;87(2):173-8
pubmed: 24428240
Mov Disord. 2007 Nov 15;22(15):2162-9
pubmed: 17712842
J Comp Neurol. 1985 May 15;235(3):343-59
pubmed: 3998215
Behav Brain Res. 2014 Mar 15;261:240-8
pubmed: 24398265
Neurobiol Aging. 2003 Jan-Feb;24(1):25-35
pubmed: 12493548
Mov Disord. 2011 Jun;26(7):1329-36
pubmed: 21484870
Neurology. 2005 Jul 26;65(2):299-301
pubmed: 16043804
Exp Brain Res. 2019 Sep;237(9):2269-2278
pubmed: 31161414
Neurology. 2012 Oct 30;79(18):1898-907
pubmed: 23077007
Annu Rev Neurosci. 2005;28:157-89
pubmed: 16022593
Neuroimage. 2010 Apr 1;50(2):572-6
pubmed: 20006712
Eur J Hum Genet. 2009 Oct;17(10):1359-62
pubmed: 19367323
Front Neurol. 2018 Aug 22;9:695
pubmed: 30186228
Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1139-1147
pubmed: 27615674
Neuroimage. 2012 Jul 16;61(4):1277-86
pubmed: 22484411
J Neurophysiol. 2003 Nov;90(5):3330-40
pubmed: 12840082
Cerebellum. 2016 Oct;15(5):546-51
pubmed: 27108270
Drug Discov Today. 2018 Feb;23(2):333-348
pubmed: 29154758
J Neurodev Disord. 2019 Jan 21;11(1):2
pubmed: 30665341
Neuroimage Clin. 2017 Dec 09;17:761-767
pubmed: 29527483
Brain Cogn. 2009 Mar;69(2):291-5
pubmed: 18789568
J Neurol. 2011 Jul;258(7):1268-80
pubmed: 21298283
JAMA. 2004 Jan 28;291(4):460-9
pubmed: 14747503
Neuroimage. 1997 Oct;6(3):218-29
pubmed: 9344826
Am J Med Genet A. 2008 Apr 15;146A(8):1009-16
pubmed: 18348275
Cerebellum. 2016 Aug;15(4):475-82
pubmed: 26298472
Physiol Rev. 1992 Oct;72(4):967-1017
pubmed: 1438583
Neurology. 2008 Apr 15;70(16 Pt 2):1397-402
pubmed: 18057320
Mov Disord. 2006 May;21(5):699-704
pubmed: 16450347
JAMA Neurol. 2013 Aug;70(8):1022-9
pubmed: 23753897
J Alzheimers Dis. 2017;59(1):169-187
pubmed: 28598839
Circ Cardiovasc Genet. 2011 Apr;4(2):188-96
pubmed: 21292865
Neurobiol Aging. 2017 Jul;55:11-19
pubmed: 28391068
J Neurosci. 1991 Jan;11(1):168-90
pubmed: 1702462
Mitochondrion. 2020 May;52:157-162
pubmed: 32173566
Trends Neurosci. 2000 Dec;23(12):613-7
pubmed: 11137151
Neuroimage. 2005 Mar;25(1):253-66
pubmed: 15734360
Mov Disord. 2004 Oct;19(10):1196-202
pubmed: 15390014
Nat Commun. 2018 Jul 18;9(1):2807
pubmed: 30022026
AJNR Am J Neuroradiol. 2002 Nov-Dec;23(10):1757-66
pubmed: 12427636
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7900-5
pubmed: 27357684
Brain Connect. 2017 Apr;7(3):152-171
pubmed: 28398812
Brain. 2006 Jan;129(Pt 1):243-55
pubmed: 16332642
Neuron. 2017 Jan 18;93(2):331-347
pubmed: 28065649
Muscle Nerve. 2000 Apr;23(4):600-12
pubmed: 10716772
Neurosci Biobehav Rev. 2009 Jun;33(6):900-8
pubmed: 19428499
Neurology. 2006 Oct 24;67(8):1426-31
pubmed: 17060569
Cereb Cortex. 2009 Nov;19(11):2640-50
pubmed: 19254959
Neurol Genet. 2018 Jul 27;4(4):e246
pubmed: 30065951
Neuron. 2013 May 8;78(3):440-55
pubmed: 23602499
Neurosci Lett. 2012 Apr 18;514(2):204-9
pubmed: 22425717
Front Integr Neurosci. 2019 Oct 02;13:56
pubmed: 31632248
Brain Cogn. 2008 Dec;68(3):415-35
pubmed: 19028266
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7350-5
pubmed: 15883384
Am J Hum Genet. 2003 Apr;72(4):869-78
pubmed: 12638084
J Comp Neurol. 1988 Mar 15;269(3):392-413
pubmed: 2453534
J Neurophysiol. 2015 Apr 1;113(7):1989-2001
pubmed: 25552638
J Neurol Sci. 1997 Feb 12;145(2):205-11
pubmed: 9094050
Front Genet. 2019 Mar 28;10:249
pubmed: 30984240
Hum Mov Sci. 2017 Aug;54:41-50
pubmed: 28371663
J Neurophysiol. 2006 Feb;95(2):922-31
pubmed: 16267114
Neuroimage. 2006 Oct 15;33(1):127-38
pubmed: 16904911
Am J Med Genet. 1994 Jul 15;51(4):374-7
pubmed: 7943002
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683

Auteurs

Walker S McKinney (WS)

Life Span Institute and Kansas Center for Autism Research and Training (K-CART), Clinical Child Psychology Program, University of Kansas, 1000 Sunnyside Avenue, Lawrence, KS 66045, USA. Electronic address: wmckinney@ku.edu.

James Bartolotti (J)

Life Span Institute and Kansas Center for Autism Research and Training (K-CART), Clinical Child Psychology Program, University of Kansas, 1000 Sunnyside Avenue, Lawrence, KS 66045, USA. Electronic address: jbartolotti@ku.edu.

Pravin Khemani (P)

Department of Neurology, Swedish Neuroscience Institute, 550 17th Avenue, Suite 400, Seattle, WA 98122, USA. Electronic address: Pravin.Khemani@swedish.org.

Jun Yi Wang (JY)

Center for Mind and Brain, University of California, Davis, 267 Cousteau Place, Davis, CA 95618, USA. Electronic address: jyiwang@ucdavis.edu.

Randi J Hagerman (RJ)

MIND Institute and Department of Pediatrics, University of California, Davis School of Medicine, 2825 50th St., Sacramento, CA 95817, USA. Electronic address: rjhagerman@ucdavis.edu.

Matthew W Mosconi (MW)

Life Span Institute and Kansas Center for Autism Research and Training (K-CART), Clinical Child Psychology Program, University of Kansas, 1000 Sunnyside Avenue, Lawrence, KS 66045, USA. Electronic address: mosconi@ku.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH